The effect of ginseng supplementation on CVD risk factors: a comprehensive systematic review and dose–response meta-analysis
Open Access
- 9 September 2025
- journal article
- review article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 134 (7) , 529-577
Abstract
Although numerous clinical studies suggest that ginseng supplementation may benefit CVD risk factors, results remain inconclusive. This systematic review and meta-analysis evaluated the effects of ginseng supplementation on CVD-related risk factors. Relevant studies were identified through electronic searches in Embase, Web of Science, Scopus, PubMed and CENTRAL up to August 2024. Statistical analyses, including a random effects model, meta-regression and non-linear modelling, were used to assess heterogeneity, dose–response relationships and the overall effects of ginseng supplementation. A total of 70 studies, published between 1998 and 2024 and involving 4506 participants, were included. Ginseng supplementation significantly affected several biochemical markers, including high-sensitivity C-reactive protein (standardised mean difference (SMD): −0·23; 95 % CI: −0·38, −0·08; P = 0·002), gamma-glutamyl transferase (SMD: −0·20; 95 % CI: −0·36, −0·04; P = 0·015), glutathione reductase (SMD: 0·90; 95 % CI: 0·38, 1·42; P = 0·001), reactive oxygen species (SMD: −0·94; 95 % CI: −1·27, −0·60; P < 0·001) and superoxide dismutase (SMD: 0·48; 95 % CI: 0·10, 0·87; P = 0·014). Meta-regression analysis showed significant linear associations between ginseng dosage and Homeostatic Model Assessment for Insulin Resistance ( P = 0·044) and between supplementation duration and malondialdehyde ( P = 0·007). Dose–response analysis revealed significant associations between ginseng dose and fasting blood glucose ( P < 0·001), high-sensitivity C-reactive protein ( P = 0·043), IL-6 ( P = 0·041), diastolic blood pressure ( P = 0·022), IL-10 ( P = 0·048), fasting insulin ( P = 0·012) and total protein ( P = 0·010). Supplementation duration was positively associated with malondialdehyde levels ( P = 0·008). Ginseng supplementation was associated with improvements in inflammatory markers, liver function and oxidative stress parameters. No significant effects were observed on anthropometric indices, blood pressure, glycaemic profile, lipid profile, adipokines or heart rate.Keywords
This publication has 99 references indexed in Scilit:
- Dietary Patterns and Cardiovascular Diseases in Asia: A Systematic Review and Meta-AnalysisAdvances in Nutrition, 2024
- Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19Inflammopharmacology, 2023
- Polymorphisms in drug-metabolizing enzymes: Challenges and strategies2022
- The effects of ginseng on the metabolic syndrome: An updated reviewFood Science & Nutrition, 2021
- Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trialEPMA Journal, 2021
- Effects of ginseng supplementation on selected markers of inflammation: A systematic review and meta‐analysisPhytotherapy Research, 2019
- Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trialEuropean Journal of Nutrition, 2018
- Impact of extended ginsenoside Rb1 on early chronic kidney disease: a randomized, placebo-controlled studyInflammopharmacology, 2016
- Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST‐segment elevation acute myocardial infarctionPhytotherapy Research, 2011
- Variance imputation for overviews of clinical trials with continuous responseJournal of Clinical Epidemiology, 1992